Sex, one of the most gratifying acts known to humans, can be lethal. A danger exists to thwart this – hepatitis B virus …
When a tumor-targeted therapy company advances in clinical trials, pay attention. Rexahn Pharmaceuticals (NYSEMKT:RNN) should be closely watched.
New results shown at last week’s European Cancer Congress supported evidence that RX-3117 and Supinoxin, developed by Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN), work well …
Quick commercialization of drugs in clinical trials has long been held as a fantasy for makers of pharmaceuticals and biologics. With recent news, …